Back to homepage

Infectious disease

HIV: how to manage dyslipidaemia in HIV

Authors: Daniel Lee

This article aims to provide a narrative updated review on the clinical evaluation and management of dyslipidaemia in people with HIV.


Considerations for select transitions of care for people with HIV: adolescent to adult, prison to society and the postpartum period

Authors: Milena Murray, Fatima Khaleq, E Paul O’Donnell

This article discusses three transitions of care that may lead to suboptimal outcomes if people with HIV are not adequately engaged: adolescent to adult, prison to society and the postpartum period.


Experiences to date with the logistical management of long-acting cabotegravir and rilpivirine

Authors: Kamile Johnson, Mark T Sawkin

In this commentary, the authors describe experiences to date with acquiring, storing, handling, administering and billing for long-acting cabotegravir and rilpivirine through four scenarios, each of which have presented their own unique obstacles and learning curves.


Infectious disease: how to manage Gram-positive and Gram-negative pathogen conundrums with dual beta-lactam therapy

Authors: Alireza FakhriRavari, Brenda Simiyu, Taylor Morrisette, Yewande Dayo, Jacinda C Abdul-Mutakabbir

This article reviews the mechanisms of beta-lactam resistance in Gram-positive and Gram-negative bacteria, discusses the rationale for dual beta-lactam use against multidrug-resistant infections (and other scenarios in which this strategy may be most utilized in clinical practice), explores the available in vitro, in vivo and clinical data, and provides considerations for the use of dual beta-lactam therapy against Enterococcus faecalis, Listeria monocytogenes, Staphylococcus aureus, Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii pathogens.


Vitamins, supplements and COVID-19: a review of currently available evidence

Authors: Lauren Speakman, Sarah Michienzi, Melissa Badowski

The purpose of this review was to analyse clinical trials regarding vitamins and supplements for the treatment of COVID-19 infections.